MedPath

A Study of Xevinapant (Debio 1143) in Combination With Platinum-Based Chemotherapy and Standard Fractionation Intensity-Modulated Radiotherapy in Participants With Locally Advanced Squamous Cell Carcinoma of the Head and Neck, Suitable for Definitive Chemoradiotherapy (TrilynX)

Phase 3
Terminated
Conditions
Squamous Cell Carcinoma of the Head and Neck
Interventions
Radiation: Intensity Modulation Radiation Therapy (IMRT)
Drug: Placebo
Registration Number
NCT04459715
Lead Sponsor
EMD Serono Research & Development Institute, Inc.
Brief Summary

The primary objective of the study is to demonstrate superior efficacy of Xevinapant (Debio 1143) vs placebo when added to chemoradiotherapy (CRT) in locally advanced squamous cell carcinoma of the head and neck (LA-SCCHN).

Detailed Description

Not available

Recruitment & Eligibility

Status
TERMINATED
Sex
All
Target Recruitment
730
Inclusion Criteria
  • Eastern Cooperative Oncology Group performance status (ECOG PS) 0 or 1
  • Histologically confirmed diagnosis of previously untreated Locally Advanced Squamous Cell Carcinoma of the Head and Neck (LA-SCCHN) participant (stage III, IVa or IVb according to the American Joint Committee on Cancer(AJCC))/Classification of malignant tumors: T=size of the primary tumor, N=regional lymph node involvement, M=distant metastasis (TNM) Staging System, 8th Edition.) suitable for definitive ChemoRadiotherapy (CRT), of at least one of the following sites: oropharynx, hypopharynx and larynx
  • For OroPharyngeal Cancer (OPC) participants, primary tumors must be human papillomavirus (HPV)-negative as determined by p16 expression using immunohistochemistry
  • Evaluable tumor burden (measurable and/or non-measurable tumor lesions) assessed by computed tomography scan (CT-scan) or magnetic resonance imaging (MRI), based on Response evaluation criteria in solid tumors (RECIST) version 1.1
  • Peripheral neuropathy less than (<) grade 2
  • Adequate hematologic, renal and hepatic function
  • Other protocol defined inclusion criteria may apply
Exclusion Criteria
  • Primary tumor of nasopharynx, paranasal sinuses, nasal or oral cavity, salivary, thyroid or parathyroid gland pathologies, skin or unknown primary site
  • Metastatic disease (stage IVc as per AJCC/TNM, 8th Ed.)
  • Prior definitive or adjuvant Radiotherapy (RT) and/or radical surgery to the head and neck region which may jeopardize the primary tumor irradiation plan, or any other prior SCCHN systemic treatment, including investigational agents
  • Documented weight loss of >10% during the last 4 weeks prior to randomization (unless adequate measures are undertaken for nutritional support), OR plasmatic albumin < 3.0 g/dL. No albumin transfusions are allowed within 2 weeks before randomization
  • Known allergy to Xevinapant (Debio 1143), cisplatin, carboplatin, other platinum-based agent or any excipient known to be present in any of these products or in the placebo formulation
  • other protocol defined exclusion criteria may apply

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Xevinapant (Debio 1143)Xevinapant (Debio 1143)Participants will receive: Concomitant chemo-radiation therapy period (Cycles 1-3): * Radiotherapy * Cisplatin * Xevinapant (Debio 1143) Monotherapy period (Cycles 4-6): • Xevinapant (Debio 1143)
Xevinapant (Debio 1143)CisplatinParticipants will receive: Concomitant chemo-radiation therapy period (Cycles 1-3): * Radiotherapy * Cisplatin * Xevinapant (Debio 1143) Monotherapy period (Cycles 4-6): • Xevinapant (Debio 1143)
Xevinapant (Debio 1143)Intensity Modulation Radiation Therapy (IMRT)Participants will receive: Concomitant chemo-radiation therapy period (Cycles 1-3): * Radiotherapy * Cisplatin * Xevinapant (Debio 1143) Monotherapy period (Cycles 4-6): • Xevinapant (Debio 1143)
PlaceboCisplatinParticipants will receive: Concomitant chemo-radiation therapy period (Cycles 1-3): * Radiotherapy * Cisplatin * Matched placebo Monotherapy period (Cycles 4-6): • Matched placebo
PlaceboIntensity Modulation Radiation Therapy (IMRT)Participants will receive: Concomitant chemo-radiation therapy period (Cycles 1-3): * Radiotherapy * Cisplatin * Matched placebo Monotherapy period (Cycles 4-6): • Matched placebo
PlaceboPlaceboParticipants will receive: Concomitant chemo-radiation therapy period (Cycles 1-3): * Radiotherapy * Cisplatin * Matched placebo Monotherapy period (Cycles 4-6): • Matched placebo
Primary Outcome Measures
NameTimeMethod
Event-Free Survival (EFS)Up to 5 years

EFS is the time from the date of randomization to the date of first record of disease progression or death.

Secondary Outcome Measures
NameTimeMethod
Objective Response Rate (ORR)Up to 5 years

ORR defined as proportion of participants with complete response (CR) or partial response (PR) by Response Evaluation Criteria in Solid Tumors (RECIST) version 1.1, as assessed by Blinded Independent Review Committee (BIRC).

Complete Response Rate (CRR)Up to 5 years

CRR defined as proportion of participants with complete response (CR) as assessed by Blinded Independent Review Committee (BIRC).

Overall survival (OS)Up to 5 years

OS is the time from randomization to death due to any cause.

Changes from Baseline in Global Health Status/Quality of Life (GHS/QoL) and Fatigue SymptomPrior to the first dose of study treatment (Baseline) and at the time of last follow-up (Up to 5 years)

Change from baseline in GHS/QoL and Fatigue Symptom using the European Organization for Research and Treatment of Cancer (EORTC) Quality of Life Core Questionnaire (EORTC QLQ-C30)

Changes from Baseline in Swallowing and Pain SymptomsPrior to the first dose of study treatment (Baseline) and at the time of last follow-up (Up to 5 years)

Change from baseline in swallowing, and pain symptoms using the EORTC Head and Neck Questionnaire (EORTC QLQ-H\&N35)

Progression-Free Survival (PFS)Up to 5 years

PFS is the time from randomization to the earliest between PFS event or End of Study (EOS)

Locoregional Control (LRC)From randomization to the earliest between PFS event (progression at the site of the primary tumor or the locoregional lymph nodes) or EOS (Up to 5 years)
Duration of Response (DOR)Up to 5 years

Duration of response (DoR) defined as the time from the first evidence of response (partial or complete, as assessed by the BIRC according to RECIST v1.1) to the first occurrence of progression (radiological or clinical, as assessed by the BIRC) or death from any cause.

Number of Participants with Radical Salvage SurgeryUp to 5 years
Time to Subsequent Systemic Cancer TreatmentsUp to 5 years
Safety and Tolerability as assessed by incidence and severity of Adverse Events (AEs), Serious Adverse Events (SAEs), AEs of Special Interest (AESIs), Changes in Laboratory Values, Vital Signs, Electrocardiogram (ECGs) and Extent of ExposureFrom signed informed consent to EOS (within 6.8 years)

Trial Locations

Locations (285)

Inventa Center for Cancer Research At Fort Wayne Medical Oncology and Hematology

🇺🇸

Fort Wayne, Indiana, United States

Dana-Farber Cancer Institute

🇺🇸

Boston, Massachusetts, United States

Medical center of Yuriy Spizhenko, Soborna Vulytsia

🇺🇦

Kyiv, Ukraine

CHU UCL Namur Site Sainte Elisabeth

🇧🇪

Namur, Belgium

Universitair Ziekenhuis Antwerpen

🇧🇪

Edegem, Belgium

Centre Hospitalier de l'Ardenne (CHA)

🇧🇪

Libramont, Belgium

Hopital de Jolimont, Rue Ferrer

🇧🇪

La Louvière, Belgium

A.Z. Nikolaas

🇧🇪

Sint-Niklaas, Belgium

UZ Leuven, Radiotherapy & Oncology

🇧🇪

Leuven, Belgium

Instituto Português de Oncologia de Coimbra Francisco Gentil, EPE

🇵🇹

Coimbra, Portugal

Institute of Clinical Oncology

🇬🇪

Tbilisi, Georgia

Centro Clinico Academico

🇵🇹

Braga, Portugal

Inselspital, Bern University Hospital, Universitätsklinik für Radio-Onkologie

🇨🇭

Bern, Switzerland

Chang-Gung Memorial Hospital-Kaohsiung

🇨🇳

Kaohsiung City, Taiwan

Taichung Veterans General Hospital

🇨🇳

Taichung City, Taiwan

National Taiwan University Hospital

🇨🇳

Taipei, Taiwan

Taipei Veterans General Hospital (VGHTP)

🇨🇳

Taipei, Taiwan

Kaohsiung Medical University Memorial Hospital

🇨🇳

Kaohsiung, Taiwan

Chang Gung Medical Foundatoin Linkou Chang Gung Memorial Hospital

🇨🇳

Taoyuan City, Taiwan

Centro Hospitalar Universitário Lisboa Norte

🇵🇹

Lissabon, Portugal

Centre Hospitalier Universitaire Vaudois Lausanne

🇨🇭

Lausanne, Switzerland

China Medical University Hospital

🇨🇳

Taichung, Taiwan

Centro Hospitalar de Vila Nova de Gaia/Espinho

🇵🇹

Porto, Portugal

Centro Hospitalar Universitario São João

🇵🇹

Porto, Portugal

Hopitaux Universitaires de Geneve

🇨🇭

Geneve, Switzerland

Zhejiang Province Cancer Hospital

🇨🇳

Hangzhou, China

Jilin Cancer Hospital

🇨🇳

Changchun, China

Xiangya Hospital Central South University

🇨🇳

Changsha, China

West China Hospital of Sichuan University

🇨🇳

Chengdu, China

Affiliated Tumor Hospital of Guangxi Medical University

🇨🇳

Nanning, China

Lin Yi Cancer Hospital

🇨🇳

Shandong, China

Fudan University Shanghai Cancer Center

🇨🇳

Shanghai, China

Shanghai Ninth People's Hospital

🇨🇳

Shanghai, China

GZA Sint-Augustinus

🇧🇪

Wilrijk, Belgium

University of Colorado at Denver and Health Sciences Center

🇺🇸

Aurora, Colorado, United States

Cleveland Clinic

🇺🇸

Cleveland, Ohio, United States

Wollongong Hospital

🇦🇺

Wollongong, Australia

Gettysburg Cancer Center

🇺🇸

Gettysburg, Pennsylvania, United States

Universitätsklinik für Innere Medizin III der PMU

🇦🇹

Salzburg, Austria

Medical University of Vienna, Department of Medicine I, Division of Oncology

🇦🇹

Vienna, Austria

University Hospital Cleveland Medical Center

🇺🇸

Cleveland, Ohio, United States

Ashford Cancer Centre Research, Tennyson Centre

🇦🇺

Adelaide, Australia

Medical University of South Carolina- Hollings Cancer Center

🇺🇸

Charleston, South Carolina, United States

Hospital de Caridade de Ijui, Avenida David Jose Martins

🇧🇷

Ijuí, Brazil

Fox Chase Cancer Center

🇺🇸

Philadelphia, Pennsylvania, United States

Klinische Abteilung fur Allgemeine HNO Universitatsklinik fur Hals-, Nasen- und Ohrenheilkunde

🇦🇹

Graz, Austria

Landeskrankenhaus Salzburg

🇦🇹

Salzburg, Austria

Grand Hopital de Charleroi

🇧🇪

Charleroi, Belgium

CHU Montréal

🇨🇦

Montreal, Canada

Hospital Santa Rita Centro de Pesquisa Clínica Novos Tratamentos Em Câncer

🇧🇷

Porto Alegre, Brazil

Peter MacCallum Cancer Centre

🇦🇺

Melbourne, Australia

Hospital Aleman

🇦🇷

Buenos Aires, Argentina

University South Hospital

🇺🇸

Ann Arbor, Michigan, United States

St Vincents Hospital Melbourne

🇦🇺

Fitzroy, Australia

London Regional Cancer Program, London Health Sciences Centre

🇨🇦

London, Canada

Instituto Medico Especialazado Alexander Fleming

🇦🇷

Buenos Aires, Argentina

St Vincents Hospital

🇦🇺

Darlinghurst, Australia

Evex Hospitals Oncology Center

🇬🇪

Kutaisi, Georgia

JSC "Evex Hospitals"

🇬🇪

Tbilisi, Georgia

CAMPUS CHARITÉ MITTE, Klinik f.Strahlentherapie

🇩🇪

Berlin, Germany

Istituto di Candiolo IRCCS

🇮🇹

Candiolo, Italy

Uzsoki Utcai Korhaz Onkologiai Osztaly

🇭🇺

Budapest, Hungary

Universitätsklinikum Hamburg-Eppendorf

🇩🇪

Hamburg, Germany

Petz Aladár Megyei Kórház Onkoradiológiai Osztály

🇭🇺

Győr, Hungary

Attikon University Hospital

🇬🇷

Athens, Greece

Azienda Sanitaria Ospedaliera Santa Croce e Carle - Oncologia Medica -Ospedale Carle

🇮🇹

Cuneo, Italy

Universitaetsklinikum Regensburg

🇩🇪

Regensburg, Germany

Research Fund of the Hadassah Medical Organization

🇮🇱

Jerusalem, Israel

Pecsi Tudomanyegyetem Klinikai Kozpont Onkoterapias Intazet

🇭🇺

Pécs, Hungary

Institut Gustave Roussy - Service de radiotherapie

🇫🇷

Villejuif, France

Charité - Universitätsmedizin Berlin Campus Virchow

🇩🇪

Berlin, Germany

New Hospitals

🇬🇪

Tbilisi, Georgia

Centre Oscar Lambret

🇫🇷

Lille, France

Centre Jean Perrin CLCC

🇫🇷

Clermont Ferrand, France

Academician Fridon Todua Medical Center-Ltd Research Institute of Clinical Medicine

🇬🇪

Tbilisi, Georgia

LEPL First University Clinic of Tbilisi State Medical University

🇬🇪

Tbilisi, Georgia

Department of radiation oncology, University Hospital Essen

🇩🇪

Essen, Germany

Agioi Anargiroi General Oncology Hospital of Kifissia

🇬🇷

Athens, Greece

Theagenio Anticancer Hospital

🇬🇷

Thessaloníki, Greece

IRCCS AOU San Martino

🇮🇹

Genova, Italy

Istituto Oncologico Veneto Irccs

🇮🇹

Padova, Italy

Tokyo Medical University Hospital

🇯🇵

Tokyo, Japan

Sheba Medical Center

🇮🇱

Ramat Gan, Israel

University Medical Center Schleswig-Holstein, Campus Kiel

🇩🇪

Kiel, Germany

Strahlenklinik des Uni-Klinikums

🇩🇪

Erlangen, Germany

Szegedi Tudományegyetem ÁOK Onkoterápiás Klinika

🇭🇺

Szeged, Hungary

Centro di Riferimento Oncologico

🇮🇹

Aviano, Italy

Azienda Socio Sanitaria Territoriale (ASST) degli Spedali Civili di Brescia

🇮🇹

Brescia, Italy

Univesitätsklinikum Essen (AöR) Klinikum und Poliklinik für Strahlentherapie

🇩🇪

Essen, Germany

Rabin Medical Center

🇮🇱

Petach Tiqva, Israel

Universitaetsmedizin Rostock

🇩🇪

Rostock, Germany

Osaka International Cancer Institute

🇯🇵

Osaka, Japan

Orszagos Onkologiai Intezet Sugarterapias Osztaly

🇭🇺

Budapest, Hungary

Az. USL 6 Ospedali Riuniti-Ospedale di Livorno

🇮🇹

Livorno, Italy

National Cancer Center

🇰🇷

Goyang-si, Korea, Republic of

National Cancer Center Hospital East

🇯🇵

Chiba, Japan

Rambam Healthcare Campus

🇮🇱

Haifa, Israel

Ospedale "Vito Fazzi" Lecce

🇮🇹

Lecce, Italy

AOU "Luigi Vanvitelli"

🇮🇹

Napoli, Italy

Policlinico di Modena

🇮🇹

Modena, Italy

AORN Ospedale dei Monaldi

🇮🇹

Napoli, Italy

National Cancer Center Hospital

🇯🇵

Chuo-ku Tokyo, Japan

Fundacio Althaia

🇪🇸

Manresa, Spain

Hospital 12 de Octubre

🇪🇸

Madrid, Spain

Clatterbridge Cancer Centre NHS Foundation Trust

🇬🇧

Wirral, United Kingdom

Regents of the University of California

🇺🇸

San Francisco, California, United States

UCSF

🇺🇸

San Francisco, California, United States

Henry Ford Health System

🇺🇸

Detroit, Michigan, United States

University of Cincinnati Medical Center

🇺🇸

Cincinnati, Ohio, United States

University of Oklahoma Health Sciences Center- Stephenson Cancer Center

🇺🇸

Oklahoma City, Oklahoma, United States

Providence Portland Medical Center

🇺🇸

Portland, Oregon, United States

MD Anderson

🇺🇸

Houston, Texas, United States

IHO Corporation/Utah Cancer Specialists

🇺🇸

Salt Lake City, Utah, United States

Azienda Ospedaliero-Universitaria Careggi

🇮🇹

Firenze, Italy

IRCCS - Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST)

🇮🇹

Meldola, Italy

Istituto Nazionale dei Tumori

🇮🇹

Milan, Italy

Azienda Ospedaliero Universitaria di Parma

🇮🇹

Parma, Italy

Fundação Pio XII- Hospital de Cancer de Barretos, Rua Antenor Duarte Vilela

🇧🇷

Barretos, Brazil

Liga Norte Riograndense Contra o Câncer, Avenida Miguel Castro

🇧🇷

Natal, Brazil

Centro Gaúcho Integrado, Rua Costa

🇧🇷

Porto Alegre, Brazil

Hospital Santa Rita, Centro de Pesquisa Clínica Novos Tratamentos Em Câncer

🇧🇷

Porto Alegre, Brazil

CEPHO - Centro de Estudos e Pesquisas de Hematologia e Oncologia - FMABC - Faculdade de Medicina do ABC

🇧🇷

Santo André, Brazil

Oswaldo Cruz German Hospital

🇧🇷

São Paulo, Brazil

University Hospital Kyoto Prefectural University of Medicine

🇯🇵

Kamigyo-ku, Japan

National Hospital Organization Shikoku Cancer Center

🇯🇵

Matsuyama, Japan

Universitatsklinikum Leipzig AoR, Klinik für Strahlentherapie

🇩🇪

Leipzig, Germany

Hospital Civil (Hospital Regional Universitario)

🇪🇸

Málaga, Spain

University Hospital hradec Kralové

🇨🇿

Hradec Králové, Czechia

Princess Alexandra Hospital, Cancer Trials Unit

🇦🇺

Woolloongabba, Australia

Clinica Universitaria Reina Fabiola

🇦🇷

Cordoba, Argentina

Instituto de Oncologia de Rosario

🇦🇷

Santa Fe, Argentina

Ohio State University

🇺🇸

Columbus, Ohio, United States

The University of Alabama at Birmingham - Hazelrig-Salter Radiation Oncology Center (HSROC)

🇺🇸

Birmingham, Alabama, United States

Banner MD Anderson Cancer Center

🇺🇸

Gilbert, Arizona, United States

UC San Diego Moores Cancer Center

🇺🇸

La Jolla, California, United States

The Oncology Institute of Hope & Innovation

🇺🇸

Whittier, California, United States

Yale Cancer Center

🇺🇸

New Haven, Connecticut, United States

ASCLEPES Research Centers

🇺🇸

Weeki Wachee, Florida, United States

Lombardi Comprehensive Cancer Center, Georgetown University Medical Center

🇺🇸

Washington, District of Columbia, United States

IACT Health, John B. Amos Cancer Center

🇺🇸

Columbus, Georgia, United States

Beth Israel Deaconess (BI Lahey)/Harvard Cancer Center

🇺🇸

Boston, Massachusetts, United States

Norton Cancer Institute, Louisville, Kentucky, Brownsboro Hospital Campus

🇺🇸

Louisville, Kentucky, United States

Ashland-Bellefonte Cancer Center

🇺🇸

Ashland, Kentucky, United States

Massachusetts General Hospital

🇺🇸

Boston, Massachusetts, United States

MidAmerica Cancer Care

🇺🇸

Kansas City, Missouri, United States

Washington University School of Medicine

🇺🇸

Saint Louis, Missouri, United States

Comprehensive Cancer Centers of Nevada

🇺🇸

Las Vegas, Nevada, United States

NYU Langone Hospital-Long Island Oncology

🇺🇸

Mineola, New York, United States

Comprehensive Cancer Center of Nevada (Southern Hills) (USA)

🇺🇸

Las Vegas, Nevada, United States

Wake Forest University School of Medicine

🇺🇸

Winston-Salem, North Carolina, United States

Clinica Viedma

🇦🇷

Viedma, Argentina

Hospital de Base de Sao Jose do Rio Preto, Av. Brigadeiro Faria Lima

🇧🇷

São José Do Rio Preto, Brazil

Instituto do Cancer do Estado de Sao Paulo (ICESP)

🇧🇷

São Paulo, Brazil

CIUSSS de l'Est de l'Ile de Montreal - Hopital Maisonneuve-Rosemont

🇨🇦

Montreal, Canada

Hopital Maisonneuve-Rosemont

🇨🇦

Montreal, Canada

CHU de Quebec-Université Laval

🇨🇦

Québec, Canada

Beijing Cancer Hospital

🇨🇳

Beijing, China

Hokkaido University Hospital

🇯🇵

Kita-Ku, Japan

Sunnybrook Research Institute

🇨🇦

Toronto, Canada

Hunan Cancer Hospital

🇨🇳

Changsha, China

Peking Union Medical College Hospital

🇨🇳

Beijing, China

The 5th Affiliated Hospital of Sun yet-sen university

🇨🇳

Guangdong, China

The 2nd Affiliated Hospital of Zhejiang University School of Medicine

🇨🇳

Hangzhou, China

Harbin Medical University Cancer Hospital

🇨🇳

Harbin, China

Shantou University Cancer Hospital

🇨🇳

Shantou, China

Liaoning Cancer Hospital & institute

🇨🇳

Shenyang, China

Tianjin Medical University Cancer Institute & Hospital

🇨🇳

Tianjin, China

Henan Cancer Hospital

🇨🇳

Zhengzhou, China

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

🇨🇳

Wuhan, China

Tongji Hospital/Tongji Medical College, Huazhong University of Science

🇨🇳

Wuhan, China

CHU Amiens Picardie - Hopital Sud

🇫🇷

Amiens, France

Fakultni Nemocnice Ostrava

🇨🇿

Ostrava-Poruba, Czechia

KOC KNTB a.s. Zlín

🇨🇿

Zlín, Czechia

Institut de Cancérologie de l Ouest (ICO)

🇫🇷

Angers, France

CHRU de Brest Hopital Morvan

🇫🇷

Brest, France

CHU de Grenoble

🇫🇷

Grenoble Cedex 9, France

Centre Guillaume Le Conquerant

🇫🇷

le Havre, France

Clinique Victor Hugo

🇫🇷

Le Mans, France

Centre hospitalier Libourne

🇫🇷

Libourne, France

Hôpital du Scorff

🇫🇷

Lorient, France

Service d'Oncologie Médicale, CHU Timone

🇫🇷

Marseille, France

Centre Leon Berard

🇫🇷

Lyon, France

Hôpital Nord Franche Comté

🇫🇷

Montbeliard, France

Institut Regional du Cancer de Montpellier

🇫🇷

Montpellier, France

CHU Nimes

🇫🇷

Nimes, France

LHopital prive du Confluent Nantes

🇫🇷

Nantes Cedex 2, France

CCConcorde (GCS)

🇫🇷

Neuilly sur Seine, France

Institut Curie

🇫🇷

Paris, France

Centre Antoine Lacassagne

🇫🇷

Nice, France

Institut de Cancérologie de l'Ouest - Site Saint Herblain

🇫🇷

Saint Herblain, France

Centre Eugène Marquis

🇫🇷

Rennes Cedex, France

Centre Henri Becquerel CLCC

🇫🇷

Rouen Cedex, France

CHP Saint Gregoire FINESS

🇫🇷

Saint Gregoire, France

Institut Claudius Regaud - IUCT-O

🇫🇷

Toulouse, France

ICANS

🇫🇷

Strasbourg, France

CHU de Tours

🇫🇷

Tours, France

Cancer Research Cent 4

🇬🇪

Tbilisi, Georgia

IRCCS-Istituto Europeodi Oncologia The European Institute of Oncology IEO

🇮🇹

Milan, Italy

ASL2_Presidio Ospedaliero San Paolo

🇮🇹

Savona, Italy

Istituto Nazionale Tumori (INT) IRCCS Fondazione "G. Pascale"

🇮🇹

Napoli, Italy

Fondazione Policlinico Universitario Agostino Gemelli

🇮🇹

Rome, Italy

Hyogo Cancer Center

🇯🇵

Hyogo, Japan

Saitama Medical University International Medical Center

🇯🇵

Hidaka, Japan

Tokai University Hospital

🇯🇵

Kanagawa, Japan

Okayama University Hospital

🇯🇵

Kita-ku, Japan

Kobe University Hospital

🇯🇵

Kobe, Japan

Cancer Institute Hospital of JFCR

🇯🇵

Koto-ku, Japan

Shizuoka Cancer Center

🇯🇵

Nagaizumi-cho, Japan

Pusan National University Hospital

🇰🇷

Busan, Korea, Republic of

National Cancer Center Hematologic Oncology

🇰🇷

Goyang-si, Korea, Republic of

Asan Medical Center, Asian Cacer Center

🇰🇷

Seoul, Korea, Republic of

Asan Medical Center

🇰🇷

Seoul, Korea, Republic of

KonKuk University Medical Center

🇰🇷

Seoul, Korea, Republic of

Korea University Anam Hospital

🇰🇷

Seoul, Korea, Republic of

Uniwersyteckie Centrum Kliniczne - Klinika Onkologii i Radioterapii

🇵🇱

Gdańsk, Poland

Seoul National University Boramae Medical Center

🇰🇷

Seoul, Korea, Republic of

Pusan National University Yangsan Hospital, Oncol & Hematology

🇰🇷

Yangsan, Korea, Republic of

Centrum Onkologii- Instytut im. Marii Sklodowskiej-Curie Oddzial w Gliwicach

🇵🇱

Gliwice, Poland

NZOZ Provita Prolife Centrum Medyczne

🇵🇱

Łódź, Poland

SP ZOZ MSWiA z W-M CO w Olsztynie

🇵🇱

Olsztyn, Poland

Centro Hospitalar Universitário do Algarve - Hospital de Faro (PRT)

🇵🇹

Faro, Portugal

Hospital de Braga

🇵🇹

Braga, Portugal

Instituto Portugues de Oncologia Porto Francisco Gentil, E.P.E

🇵🇹

Porto, Portugal

Hospital Pedro Hispano

🇵🇹

Porto, Portugal

Krasnoyarsk Regional Clinical Oncological Dispensary named after A.I.Kryzhanovsky

🇷🇺

Krasnoyarsk, Russian Federation

Kursk Regional Clinical Oncology Dispensary

🇷🇺

Kursk, Russian Federation

EuroCityClinic

🇷🇺

Saint Petersburg, Russian Federation

FGBU N.N.Blokhin Russian Cancer Research Center

🇷🇺

Moscow, Russian Federation

Saint- Petersburg Clinical Research Center of Specialized Types of Medical Care (Oncology)

🇷🇺

Saint Petersburg, Russian Federation

Republican Clinical Oncological Dispensary of Bashkortostan

🇷🇺

Ufa, Russian Federation

State Budgetary Healthcare Institution Republican Clinical Oncology Dispensary (RUS)

🇷🇺

Ufa, Russian Federation

Hospital Clinic Barcelona

🇪🇸

Barcelona, Spain

FSBI National Med Research Cancer Center N.N. Petrov

🇷🇺

Saint-Petersburg, Russian Federation

State Budgetary Institution of Healthcare of Yaroslavl region Clinical oncology hospital

🇷🇺

Yaroslavl, Russian Federation

Fundacion Centro Oncologico de Galicia (COG) "Jose Antonio Quiroga y Pineyro"

🇪🇸

A Coruña, Galicia, Spain

Hospital del Mar

🇪🇸

Barcelona, Spain

Fundacin Oncolgico de Galicia Jos Antonio Quiroga y Pieyro

🇪🇸

A Coruna, Spain

Hospital Universitari Vall d'Hebron

🇪🇸

Barcelona, Spain

Institut Català d'Oncologia Badalona

🇪🇸

Barcelona, Spain

Institut Català d'Oncologia, Hospital Duran

🇪🇸

Barcelona, Spain

Institut Català d'Oncologia

🇪🇸

Girona, Spain

Institut Universitari Dexeus-Quiron (ESP)

🇪🇸

Barcelona, Spain

Clinica Universidad de Navarra

🇪🇸

Pamplona, Spain

Hospital Reina Sofía

🇪🇸

Cordoba, Spain

Hospital Universitario Insular de Gran Canaria

🇪🇸

Las Palmas de Gran Canaria, Spain

Hospital Universitario HM Sanchinarro

🇪🇸

Madrid, Spain

Hospital Clinico San Carlos

🇪🇸

Madrid, Spain

Hospital Universitario La Paz

🇪🇸

Madrid, Spain

Hospital Ramon y Cajal

🇪🇸

Madrid, Spain

Althaia, Xarxa Assistencial

🇪🇸

Manresa, Spain

Hospital Universitario Marqués de Valdecilla. Santander

🇪🇸

Santander, Spain

Fundacion Investigacion Hospital General Universitario de Valencia FiHgU (ESP)

🇪🇸

Valencia, Spain

IVO

🇪🇸

Valencia, Spain

Hospital Universitario La Fe

🇪🇸

Valencia, Spain

Aberdeen Royal infirmary, Dept. of Oncology

🇬🇧

Aberdeen, United Kingdom

NHS Greater Glasgow and Clyde

🇬🇧

Glasgow, United Kingdom

Royal Marsden NHS Foundation Trust

🇬🇧

Chelsea, United Kingdom

Royal Surrey County Hospital

🇬🇧

Guildford, United Kingdom

The Royal Marsden NHS Foundation Trust - Sutton

🇬🇧

Sutton, United Kingdom

University Hospital Southampton NHS Foundation Trust

🇬🇧

Southampton, United Kingdom

The Christie NHS Foundation Trust

🇬🇧

Manchester, United Kingdom

Mount Vernon Cancer Centre

🇬🇧

Northwood, United Kingdom

Nottingham University Hospitals NHS Trust

🇬🇧

Nottingham, United Kingdom

Karmanos Cancer institute

🇺🇸

Detroit, Michigan, United States

University of Missouri - Ellis Fischel Cancer Center

🇺🇸

Columbia, Missouri, United States

University of Virginia Medical Center

🇺🇸

Charlottesville, Virginia, United States

National Cancer Institute

🇧🇷

Rio De Janeiro, Brazil

Columbus Regional Research Institute

🇺🇸

Columbus, Georgia, United States

Centre hospitalier Universitaire de Bordeaux

🇫🇷

Bordeaux, France

Moffitt Cancer Center

🇺🇸

Tampa, Florida, United States

Hospital Na Bulovce

🇨🇿

Prague, Czechia

Institut Sainte Catherine

🇫🇷

Avignon Cedex 9, France

The Public Hospital L'Institut de Cancerologie de Lorraine

🇫🇷

Vandoeuvre les Nancy, France

Universitaetsmedizin Mannheim UMM, Klinik fuer Hals-Nasen-Ohrenheilkunde Kopf- und Halschirurgie

🇩🇪

Mannheim, Germany

State Autonomous Healthcare Institution "Republican Clinical Oncological Dispensary of the Ministry of Healthcare of the Republic of Tatarstan"

🇷🇺

Kazan, Russian Federation

Szpitale Pomorskie Sp. z o.o.

🇵🇱

Gdynia, Poland

Kiev City Clinical Oncology Centre

🇺🇦

Kiev, Ukraine

Medical center ASKLEPION LLC

🇺🇦

Khodosivka, Ukraine

Cliniques universitaires Saint-Luc

🇧🇪

Bruxelles, Belgium

Universitair Ziekenhuis Gent UZ Gent

🇧🇪

Gent, Belgium

Charing Cross Hospital

🇬🇧

London, United Kingdom

University of Arizona Cancer Center

🇺🇸

Tucson, Arizona, United States

NYU Grossman School of Medicine

🇺🇸

New York, New York, United States

Laura and Isaac Perlmutter Cancer Center at NYU Langone Health

🇺🇸

New York, New York, United States

Fujian Cancer Hospital

🇨🇳

Fuzhou, China

© Copyright 2025. All Rights Reserved by MedPath